Sinusoidal obstruction syndrome diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:




The diagnosis of sinusoidal obstruction syndrome should be considered in any patient who has undergone hematopoietic cell transplant and develops liver dysfunction.
* The two established criteria for the clinical diagnosis of sinusoidal obstruction syndrome are:
{| class="wikitable"
! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + |LAB
! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + |FORMULA/ VARIABLE
! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + |NORMAL VALUE
! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" + |VALUE IN HHS
|-
| align="center" style="background:#DCDCDC;" + |[[Plasma glucose]] (mg/dL)
|
* Direct measurement
|
* < 200 mg/dl
|
* > 600 mg/dl
|-
| align="center" style="background:#DCDCDC;" + |Arterial pH
|
* [[Blood]] [[pH]]
|
* 7.35-7.45
|
* > 7.30
|-
| colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + |[[Anion gap]]
| colspan="1" rowspan="1" |
* (Na<sup>+</sup>) – (Cl<sup>–</sup> + HCO3<sup>–</sup>)
| colspan="1" rowspan="1" |
* 7 to 13 (mEq/L)
|
* Variable
|-
| colspan="1" rowspan="1" align="center" style="background:#DCDCDC;" + |[[Osmolality|Serum osmolality]]
| colspan="1" rowspan="1" |
* 2([[Sodium|Na]] + [[Potassium|K]]) + ([[glucose]]/18) + ([[blood]] [[urea]] [[nitrogen]]/2.8)
| colspan="1" rowspan="1" |
* 285 to 295 mOsm/kg (285 to 295 mmol/kg) of water
|
* Increased (> 320mOsm/kg)
|-
| align="center" style="background:#DCDCDC;" + |Plasma [[ketones]]
|
* Direct measurement
|
* Negative
|
* Trace or negative
|-
| align="center" style="background:#DCDCDC;" + |Urine [[ketones]]
|
* Direct measurement
|
* Negative
|
* Trace or negative
|-
| align="center" style="background:#DCDCDC;" + |[[Serum bicarbonate]]
|
* Direct measurement
|
* 23 - 29 mEq/L
|
* > 18 mEq/L
|-
| align="center" style="background:#DCDCDC;" + |[[Blood urea nitrogen]] ([[BUN]]), [[creatinine]] levels
|
* N/A
|
* [[BUN]]: 7-20 mg/dl
* [[Creatinine]] levels: 0.8-1.2mg/dl
|
* Increased ([[Dehydration]] and decreased [[renal]] [[perfusion]])
|}


==References==
==References==


{{reflist|2}}
{{reflist|2}}

Revision as of 19:58, 2 February 2018

Sinusoidal obstruction syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sinusoidal obstruction syndrome from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sinusoidal obstruction syndrome diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sinusoidal obstruction syndrome diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sinusoidal obstruction syndrome diagnostic study of choice

CDC on Sinusoidal obstruction syndrome diagnostic study of choice

Sinusoidal obstruction syndrome diagnostic study of choice in the news

Blogs on Sinusoidal obstruction syndrome diagnostic study of choice

Directions to Hospitals Treating Sinusoidal obstruction syndrome

Risk calculators and risk factors for Sinusoidal obstruction syndrome diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:


Overview

Diagnostic Criteria

The diagnosis of sinusoidal obstruction syndrome should be considered in any patient who has undergone hematopoietic cell transplant and develops liver dysfunction.

  • The two established criteria for the clinical diagnosis of sinusoidal obstruction syndrome are:
LAB FORMULA/ VARIABLE NORMAL VALUE VALUE IN HHS
Plasma glucose (mg/dL)
  • Direct measurement
  • < 200 mg/dl
  • > 600 mg/dl
Arterial pH
  • 7.35-7.45
  • > 7.30
Anion gap
  • (Na+) – (Cl + HCO3)
  • 7 to 13 (mEq/L)
  • Variable
Serum osmolality
  • 285 to 295 mOsm/kg (285 to 295 mmol/kg) of water
  • Increased (> 320mOsm/kg)
Plasma ketones
  • Direct measurement
  • Negative
  • Trace or negative
Urine ketones
  • Direct measurement
  • Negative
  • Trace or negative
Serum bicarbonate
  • Direct measurement
  • 23 - 29 mEq/L
  • > 18 mEq/L
Blood urea nitrogen (BUN), creatinine levels
  • N/A

References